Aceragen (FRA:V9Z) Current Deferred Taxes Liabilities : €0.00 Mil (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

What is Aceragen Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Aceragen's current deferred tax liabilities for the quarter that ended in Mar. 2023 was €0.00 Mil.

Aceragen Current Deferred Taxes Liabilities Historical Data

The historical data trend for Aceragen's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceragen Current Deferred Taxes Liabilities Chart

Aceragen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Aceragen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Aceragen Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Aceragen's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aceragen (FRA:V9Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (FRA:V9Z) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

505 Eagleview Boulevard, Suite 212, Exton, PA, USA, 19341

Website

https://www.aceragen.com

Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Aceragen (FRA:V9Z) Headlines

No Headlines